Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AXIMAXIM BIOTECHNOLOGIES, INC.

OTC · CIK 0001514946
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts510

Identity from submissions API

NameAXIM BIOTECHNOLOGIES, INC.
CIK0001514946
TickersAXIM
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN274092986
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone(212) 751-0001
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • AXIM INTERNATIONAL INC. (2011-03-10T00:00:00.000Z → 2014-08-13T00:00:00.000Z)
Business address
6191 CORNERSTONE COURT, E
SUITE 114
SAN DIEGO
CA
92121
CA
Mailing address
6191 CORNERSTONE COURT, E
SUITE 114
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

306 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2024-12-06 15-12G AXIM BIOTECHNOLOGIES, INC. FORM 15-12G 0001096906-24-002227 000-54296 241530376 34 8101
2024-11-13 NT 10-Q AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q 0001096906-24-002103 000-54296 241453618 34 17022
2024-10-15 4 PRIMARY DOCUMENT 0001096906-24-002004 4994
2024-10-15 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 5.01,5.02 0001096906-24-002002 000-54296 241372375 34 158600 1 1
2024-08-19 10-Q FORM 10-Q 0001096906-24-001772 000-54296 241221491 34 6542862 1 1
2024-08-13 NT 10-Q AXIM BIOTECHNOLOGIES FORM 12B-25 0001096906-24-001686 000-54296 241201621 34 16841
2024-05-22 10-Q/A FORM 10-Q/A 0001096906-24-001225 000-54296 24974126 34 6036103 1 1
2024-05-20 10-Q FORM 10-Q 0001096906-24-001202 000-54296 24964943 34 6106038 1 1
2024-05-15 NT 10-Q AXIM BIOTECHNOLOGIES FORM 12B-25 0001096906-24-001124 000-54296 24946535 34 20470
2024-04-16 10-K FORM 10-K 0001096906-24-000864 000-54296 24848779 34 7603801 1 1
2024-04-01 NT 10-K AXIM BIOTECHNOLOGIES, INC. - NT 10K 0001096906-24-000689 000-54296 24808454 34 16809
2024-03-21 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 1.01,2.03,9.01 0001096906-24-000539 000-54296 24771114 34 313100 1 1
2024-03-19 4/A PRIMARY DOCUMENT 0001096906-24-000525 8177
2024-03-19 4 PRIMARY DOCUMENT 0001096906-24-000524 5693
2024-03-19 4 PRIMARY DOCUMENT 0001096906-24-000522 5644
2024-03-19 4 PRIMARY DOCUMENT 0001096906-24-000520 5649
2024-03-19 4 PRIMARY DOCUMENT 0001096906-24-000517 5652
2024-03-19 4 PRIMARY DOCUMENT 0001096906-24-000515 5658
2024-03-19 4 PRIMARY DOCUMENT 0001096906-24-000511 5611
2024-03-19 4 PRIMARY DOCUMENT 0001096906-24-000509 5678
2024-02-13 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 1.01,3.02 0001096906-24-000199 000-54296 24629850 34 150749 1 1
2023-12-28 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 1.01,3.02,9.01 0001096906-23-002456 000-54296 231520975 34 269846 1 1
2023-11-20 10-Q FORM 10-Q 0001096906-23-002238 000-54296 231423150 34 6741923 1 1
2023-11-14 NT 10-Q AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q 0001096906-23-002168 000-54296 231402294 34 18766
2023-09-21 DEF 14C AXIM BIOTECHNOLOGIES, INC. - DEF14C 0001096906-23-001823 000-54296 231268235 34 91191
2023-08-31 PRE 14C SCHEDULE 14C INFORMATION 0001096906-23-001726 000-54296 231229123 34 89759
2023-08-21 10-Q AXIM BIOTECHNOLOGIES FORM 10-Q 0001096906-23-001655 000-54296 231188512 34 7348175 1 1
2023-08-14 NT 10-Q AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q 0001096906-23-001597 000-54296 231170220 34 16967
2023-06-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-06-09 17:00:00 9999999995-23-001716 333-272390 231006976 33 1834
2023-06-07 CORRESP filename1.htm 0001096906-23-001273 9006
2023-06-07 UPLOAD filename1.pdf 0000000000-23-006052 40329
2023-06-02 S-1 FORM S-1 0001096906-23-001240 333-272390 23989466 33 10757096 1 1
2023-06-02 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 1.01,9.01 0001096906-23-001228 000-54296 23988128 34 285919 1 1
2023-05-30 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 1.01,2.03,9.01 0001096906-23-001206 000-54296 23976071 34 202468 1 1
2023-05-30 3 PRIMARY DOCUMENT 0001096906-23-001204 4286
2023-05-25 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 5.02,9.01 0001096906-23-001188 000-54296 23960394 34 200384 1 1
2023-05-22 10-Q FORM 10-Q 0001096906-23-001168 000-54296 23945404 34 6201650 1 1
2023-05-15 NT 10-Q AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q 0001096906-23-001077 000-54296 23920876 34 16887
2023-04-17 10-K FORM 10-K 0001096906-23-000858 000-54296 23824449 34 7967212 1 1
2023-03-31 NT 10-K AXIM BIOTECHNOLOGIES, INC. - NT 10K 0001096906-23-000686 000-54296 23782043 34 17463
2023-01-27 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 1.01,2.03,9.01 0001096906-23-000219 000-54296 23562830 34 263064 1 1
2022-11-15 10-Q/A FORM 10-Q/A 0001096906-22-002783 000-54296 221390441 34 7615361 1 1
2022-11-14 10-Q FORM 10-Q 0001096906-22-002767 000-54296 221387861 34 1297489
2022-10-07 144 xsl144X01/primary_doc.xml 0000107476-22-000007 000-54296 221300626 33 5392
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002340 5557
2022-09-23 3 PRIMARY DOCUMENT 0001096906-22-002338 4533
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002337 5527
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002336 5215
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002335 5562
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002334 5935
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002333 5565
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002332 5934
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002331 5596
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002330 5569
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002329 5281
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002328 5122
2022-09-23 4 PRIMARY DOCUMENT 0001096906-22-002327 5619
2022-09-23 SC 13D SCHEDULE 13D - JUNIPER & IVY CORP 0001096906-22-002326 005-88107 221262400 34 29063
2022-09-23 3 PRIMARY DOCUMENT 0001096906-22-002325 4929
2022-09-19 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 1.01,7.01,9.01 0001096906-22-002280 000-54296 221250749 34 389167 1 1
2022-08-31 SC 13D/A SCHEDULE 13D/A - CATALINA VALENCIA 0001096906-22-002077 005-88107 221218037 34 33722
2022-08-31 4 PRIMARY DOCUMENT 0001096906-22-002075 4761
2022-08-31 SC 13D SCHEDULE 13D - GLYCODOTS, LLC 0001096906-22-002073 005-88107 221217956 34 32975
2022-08-31 3 PRIMARY DOCUMENT 0001096906-22-002071 3973
2022-08-31 SC 13D SCHEDULE 13D - CATALINA VALENCIA 0001096906-22-002069 005-88107 221217936 34 33855
2022-08-31 3 PRIMARY DOCUMENT 0001096906-22-002067 3788
2022-08-29 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 1.01,3.02,9.01 0001096906-22-002035 000-54296 221210768 34 233623 1 1
2022-08-26 4 PRIMARY DOCUMENT 0001096906-22-002027 4890
2022-08-16 10-Q FORM 10-Q 0001096906-22-001922 000-54296 221170830 34 7393199 1 1
2022-08-16 NT 10-Q AXIM BIOTECHNOLOGIES, INC. FORM NT 10-Q 0001096906-22-001911 000-54296 221167716 34 17007
2022-08-04 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-08-04 17:00:00 9999999995-22-002259 333-266305 221138427 33 1834
2022-08-02 CORRESP filename1.htm 0001096906-22-001762 9457
2022-08-02 S-1/A AXIM BIOTECHNOLOGIES, INC. - FORM S1A 0001096906-22-001752 333-266305 221126728 33 230386
2022-07-29 UPLOAD filename1.pdf 0000000000-22-008008 40306
2022-07-25 S-1 AXIM BIOTECHNOLOGIES, INC. - FORM S-1 0001096906-22-001690 333-266305 221100648 33 4409245
2022-06-14 S-8 AXIM BIOTECHNOLOGIES, INC - FORM S-8 0001096906-22-001390 333-265580 221013760 33 287614
2022-05-23 10-Q FORM 10-Q 0001096906-22-001257 000-54296 22951395 34 7031047 1 1
2022-05-17 NT 10-Q AXIM BIOTECHNOLOGIES, INC. FORM NT 10-Q 0001096906-22-001162 000-54296 22931464 34 18192
2022-04-19 10-K/A FORM 10-K/A 0001096906-22-000902 000-54296 22835697 34 9199582 1 1
2022-04-15 10-K FORM 10-K 0001096906-22-000886 000-54296 22830552 34 1968606
2022-03-31 NT 10-K AXIM BIOTECHNOLOGIES, INC. FORM 12B-25 0001096906-22-000699 000-54296 22790147 34 16637
2022-03-09 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 1.02,7.01,9.01 0001096906-22-000524 000-54296 22725873 34 198641 1 1
2022-02-16 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 1.01,1.02,2.03,3.02,9.01 0001096906-22-000353 000-54296 22644035 34 335672 1 1
2022-02-15 4 PRIMARY DOCUMENT 0001096906-22-000339 5779
2022-01-12 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 5.02 0001096906-22-000092 000-54296 22525005 34 193212 1 1
2022-01-07 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 5.02 0001096906-22-000068 000-54296 22518403 34 188772 1 1
2021-11-22 10-Q AXIM FORM 10-Q 0001096906-21-002816 000-54296 211433220 34 7089428 1 1
2021-11-15 NT 10-Q AXIM BIOTECHNOLOGIES, INC. FORM NT 10-Q 0001096906-21-002707 000-54296 211408675 34 16815
2021-08-23 10-Q AXIM BIOTECHNOLOGIES, INC. FORM 10-Q 0001096906-21-002137 000-54296 211196636 34 6711806 1 1
2021-08-16 NT 10-Q AXIM BIOTECHNOLOGIES, INC. FORM NT 10-Q 0001096906-21-002002 000-54296 211173627 34 17022
2021-08-04 8-K AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING 1.01,7.01,9.01 0001096906-21-001784 000-54296 211141410 34 285153 1 1
2021-06-22 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-06-22 17:00:00 9999999995-21-002438 333-256162 211037125 33 1834
2021-06-21 CORRESP filename1.htm 0001078782-21-000578 8398
2021-06-09 S-1/A FORM S-1/A REGISTRATION STATEMENT 0001078782-21-000551 333-256162 211005911 33 3347045
2021-06-02 10-Q/A FORM 10-Q/A AMENDED QUARTERLY REPORT 0001078782-21-000516 000-54296 21986780 34 2889311 1
2021-05-24 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-21-000487 000-54296 21955613 34 663755
2021-05-19 UPLOAD filename1.pdf 0000000000-21-006337 40179
2021-05-14 NT 10-Q FORM NT 10-Q NOTICE OF LATE QUARTERLY FILING 0001078782-21-000449 000-54296 21926211 34 16594
2021-05-14 S-1 FORM S-1 REGISTRATION STATEMENT 0001078782-21-000445 333-256162 21926015 33 2521581
2021-05-14 8-K FORM 8K CURRENT REPORT 1.01,9.01 0001078782-21-000441 000-54296 21924609 34 140104
2021-04-26 10-K/A FORM 10-K/A AMENDED ANNUAL REPORT 0001078782-21-000395 000-54296 21854481 34 3528532 1
2021-04-15 10-K FORM 10-K ANNUAL REPORT 0001078782-21-000365 000-54296 21828486 34 1467013
2021-03-30 NT 10-K FORM 12B-25 NOTICE OF LATE FILING 0001078782-21-000285 000-54296 21785734 34 17957
2020-11-27 10-Q/A FORM 10-Q/A AMENDED QUARTERLY REPORT 0001078782-20-000923 000-54296 201352546 34 3401489 1
2020-11-20 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-20-000900 000-54296 201332266 34 811252
2020-11-16 NT 10-Q FORM 12B-25 NOTICE OF LATE FILING 0001078782-20-000857 000-54296 201313020 34 17317
2020-08-18 10-Q/A FORM 10-Q/A AMENDED QUARTERLY REPORT 0001078782-20-000653 000-54296 201113695 34 3097534 1
2020-08-14 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-20-000645 000-54296 201104778 34 727417
2020-07-24 8-K FORM 8K CURRENT REPORT 5.02,5.03,9.01 0001078782-20-000562 000-54296 201044650 34 95360
2020-07-02 10-Q/A FORM 10-Q/A AMENDED QUARTERLY REPORT 0001078782-20-000525 000-54296 201010915 34 2790662 1
2020-06-29 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-20-000504 000-54296 20998510 34 586037
2020-06-29 NT 10-Q FORM 12B25 EXTENSION 0001078782-20-000503 000-54296 20998277 34 16485
2020-06-15 D xslFormDX01/primary_doc.xml 06b 0001078782-20-000436 021-368905 20961615 33 9524
2020-05-29 8-K/A FORM 8-K/A AMENDED CURRENT REPORT 9.01 0001078782-20-000386 000-54296 20922508 34 344085
2020-05-20 10-K/A FORM 10-K/A ANNUAL REPORT 0001078782-20-000359 000-54296 20894889 34 2636961 1
2020-05-14 8-K FORM 8-K CURRENT REPORT 8.01 0001078782-20-000333 000-54296 20878820 34 59128
2020-05-14 10-K FORM 10-K ANNUAL REPORT 0001078782-20-000331 000-54296 20878785 34 7994388
2020-05-13 8-K FORM 8K CURRENT REPORT 7.01,8.01,9.01 0001078782-20-000320 000-54296 20870816 34 91890
2020-05-12 8-K FORM 8K CURRENT REPORT 1.01,2.01,2.03,3.02,5.02 0001078782-20-000318 000-54296 20869921 34 64949
2020-03-27 8-K FORM 8K CURRENT REPORT 8.01 0001078782-20-000203 000-54296 20752884 34 59682
2020-03-19 8-K FORM 8K CURRENT REPORT 1.01,2.01,3.02,7.01,9.01 0001078782-20-000186 000-54296 20726264 34 6309387
2020-01-10 UPLOAD filename1.pdf 0000000000-20-000250 45704
2020-01-08 8-K FORM 8K CURRENT REPORT 1.01,7.01,9.01 0001078782-20-000007 000-54296 20515346 34 1874229
2019-12-23 CORRESP filename1.htm 0001078782-19-000939 45854
2019-12-17 8-K FORM 8K CURRENT REPORT 1.01,9.01 0001078782-19-000919 000-54296 191288404 34 116982
2019-12-17 424B5 424B5 PROSPECTUS SUPPLEMENTAL AMENDMENT 0001078782-19-000917 333-220155 191288397 33 92838
2019-11-25 UPLOAD filename1.pdf 0000000000-19-015837 48663
2019-11-14 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-19-000861 000-54296 191221068 34 3356197 1
2019-10-30 10-K/A FORM 10-K/A AMENDED ANNUAL REPORT 0001078782-19-000800 000-54296 191177142 34 21411797
2019-10-29 CORRESP filename1.htm 0001078782-19-000802 62702
2019-10-23 UPLOAD filename1.pdf 0000000000-19-014793 49454
2019-08-14 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-19-000672 000-54296 191027287 34 3145393 1
2019-07-09 8-K FORM 8K CURRENT REPORT 1.01,7.01,9.01 0001078782-19-000576 000-54296 19947193 34 67492
2019-06-04 8-K FORM 8K CURRENT REPORT 1.01,7.01,9.01 0001078782-19-000493 000-54296 19874883 34 66161
2019-05-15 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-19-000443 000-54296 19826678 34 3052316 1
2019-04-23 8-K FORM 8K CURRENT REPORT 1.01,7.01,9.01 0001078782-19-000366 000-54296 19762059 34 26313
2019-04-08 10-K FORM 10-K ANNUAL REPORT 0001078782-19-000304 000-54296 19737680 34 3390633 1
2019-04-04 8-K FORM 8-K CURRENT REPORT 5.02,7.01 0001078782-19-000294 000-54296 19731568 34 31446
2019-04-01 NT 10-K FORM NT 10-K NOTICE OF LATE FILING 0001078782-19-000270 000-54296 19718459 34 16663
2019-02-26 8-K FORM 8-K CURRENT REPORT 5.01,9.01 0001078782-19-000177 000-54296 19633175 34 97566
2019-01-15 8-K FORM 8-K CURRENT REPORT 7.01,9.01 0001078782-19-000057 000-54296 19526542 34 2777562
2019-01-08 8-K FORM 8-K CURRENT REPORT 5.02,7.01,9.01 0001078782-19-000021 000-54296 19514874 34 256193
2018-12-07 8-K FORM 8-K CURRENT REPORT 1.01,9.01 0001078782-18-001400 000-54296 181224134 34 249718
2018-11-14 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-18-001314 000-54296 181183205 34 2740324 1
2018-09-13 8-K FORM 8-K CURRENT REPORT 1.01,7.01,9.01 0001078782-18-000977 000-54296 181068571 34 99231
2018-08-27 8-K FORM 8-K CURRENT REPORT 1.01,7.01,9.01 0001078782-18-000920 000-54296 181039330 34 99881
2018-08-17 10-Q/A FORM 10-Q/A AMENDED QUARTERLY REPORT 0001078782-18-000892 000-54296 181025342 34 2203791 1
2018-08-14 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-18-000863 000-54296 181018047 34 563796
2018-05-21 D xslFormDX01/primary_doc.xml 06b 0001078782-18-000588 021-312837 18848117 33 11880
2018-05-18 10-Q/A FORM 10-Q/A AMENDED QUARTERLY REPORT 0001078782-18-000580 000-54296 18844404 34 2477259 1
2018-05-15 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-18-000546 000-54296 18832529 34 522924
2018-05-11 8-K CURRENT REPORT ON FORM 8-K 1.01 0001078782-18-000533 000-54296 18828009 34 14020
2018-04-18 8-K FORM 8K CURRENT REPORT 1.01,9.01 0001078782-18-000452 000-54296 18761594 34 109158
2018-04-18 424B5 424B5 PROSPECTUS SUPPLEMENT 0001078782-18-000450 333-220155 18761577 33 383805
2018-04-06 4 PRIMARY DOCUMENT 0001078782-18-000415 4464
2018-04-05 8-K FORM 8K CURRENT REPORT 1.01,7.01,9.01 0001078782-18-000411 000-54296 18741420 34 23852
2018-03-15 10-K FORM 10-K ANNUAL REPORT 0001078782-18-000306 000-54296 18693148 34 3188950 1
2017-11-20 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-17-001610 000-54296 171213242 34 14040426 1
2017-11-15 NT 10-Q FORM NT 10-Q NOTICE OF LATE QUARTERLY FILING 0001078782-17-001589 000-54296 171203466 34 15863
2017-09-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2017-09-14 16:00:00 9999999995-17-002358 333-220155 171086759 33 1840
2017-09-14 UPLOAD filename1.pdf 0000000000-17-032712 140392
2017-09-14 10-Q/A FORM 10QA AMENDED QUARTERLY REPORT 0001078782-17-001266 000-54296 171085004 34 2401963 1
2017-09-14 10-Q/A FORM 10QA AMENDED QUARTERLY REPORT 0001078782-17-001264 000-54296 171084997 34 2360314 1
2017-09-14 10-K/A FORM 10-KA AMENDED ANNUAL REPORT 0001078782-17-001262 000-54296 171084991 34 3392472 1
2017-09-14 UPLOAD filename1.pdf 0000000000-17-032513 146046
2017-09-11 CORRESP filename1.htm 0001078782-17-001240 7453
2017-09-06 UPLOAD filename1.pdf 0000000000-17-031507 138112
2017-08-24 S-3 FORM S-3 REGISTRATION STATEMENT 0001078782-17-001212 333-220155 171049945 33 323439
2017-08-21 10-Q FORM 10Q QUARTERLY REPORT 0001078782-17-001184 000-54296 171043032 34 2393247 1
2017-08-14 NT 10-Q FORM NT 10Q NOTICE OF LATE QUARTERLY FILING 0001078782-17-001120 000-54296 171029201 34 15548
2017-06-26 8-K/A FORM 8K/A AMENDED CURRENT REPORT 1.01,2.03,3.02,9.01 0001078782-17-000908 000-54296 17928536 34 22553490
2017-06-23 3 PRIMARY DOCUMENT 0001078782-17-000913 4111
2017-06-23 3 PRIMARY DOCUMENT 0001078782-17-000912 4121
2017-06-23 3 PRIMARY DOCUMENT 0001078782-17-000911 4103
2017-06-23 3 PRIMARY DOCUMENT 0001078782-17-000910 4121
2017-06-23 3 PRIMARY DOCUMENT 0001078782-17-000909 4124
2017-06-16 8-K FORM 8K CURRENT REPORT 1.01,2.03,3.02,9.01 0001078782-17-000877 000-54296 17916858 34 16965
2017-05-22 10-Q FORM 10Q QUARTERLY REPORT 0001078782-17-000758 000-54296 17860640 34 2284552 1
2017-05-17 8-K FORM 8-K CURRENT REPORT 7.01,9.01 0001078782-17-000720 000-54296 17849851 34 18793
2017-05-16 NT 10-Q FORM12B25 NOTICE OF LATE FILING 0001078782-17-000700 000-54296 17847822 34 18685
2017-05-15 8-K FORM 8-K CURRENT REPORT 8.01 0001078782-17-000654 000-54296 17842626 34 12181
2017-04-19 10-K/A FORM 10-K/A AMENDED ANNUAL REPORT 0001078782-17-000517 000-54296 17769593 34 2821016 1
2017-04-17 10-K FORM 10-K ANNUAL REPORT 0001078782-17-000498 000-54296 17765104 34 542029
2017-03-31 NT 10-K FORM12B25 NOTICE OF LATE FILING 0001078782-17-000389 000-54296 17729361 34 18638
2017-03-28 8-K FORM 8-K CURRENT REPORT 7.01,9.01 0001078782-17-000364 000-54296 17719046 34 19770
2017-03-22 8-K FORM 8-K CURRENT REPORT 7.01,9.01 0001078782-17-000342 000-54296 17706376 34 21849
2017-03-01 SC 13D/A SCHEDULE 13D/A1 0001078782-17-000273 005-88107 17650562 34 32862
2017-03-01 SC 13D/A SCHEDULE 13D/A1 0001078782-17-000271 005-88107 17650551 34 32288
2017-02-28 5/A PRIMARY DOCUMENT 0001078782-17-000274 6731
2017-02-15 5 PRIMARY DOCUMENT 0001078782-17-000218 6654
2017-02-15 5 PRIMARY DOCUMENT 0001078782-17-000217 8260
2017-02-15 5 PRIMARY DOCUMENT 0001078782-17-000216 8321
2017-01-19 8-K FORM 8-K CURRENT REPORT 8.01 0001078782-17-000094 000-54296 17534574 34 14291
2017-01-10 8-K FORM 8-K CURRENT REPORT 8.01 0001078782-17-000045 000-54296 17520846 34 11951
2016-12-30 8-K FORM 8-K CURRENT REPORT 8.01 0001078782-16-004029 000-54296 162076154 34 12152
2016-12-13 8-K FORM 8-K CURRENT REPORT 8.01 0001078782-16-003943 000-54296 162049738 34 11991
2016-11-30 10-Q/A FORM 10-Q/A AMENDED QUARTERLY REPORT 0001078782-16-003875 000-54296 162023734 34 2298047 1
2016-11-21 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-16-003849 000-54296 162011094 34 104963162
2016-11-14 NT 10-Q FORM12B25 NOTICE OF LATE FILING 0001078782-16-003770 000-54296 161993676 34 18659
2016-08-25 10-Q/A FORM 10-Q/A AMENDED QUARTERLY REPORT 0001078782-16-003347 000-54296 161851422 34 1709768 1
2016-08-22 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-16-003327 000-54296 161846036 34 29560687
2016-08-22 8-K FORM 8-K CURRENT REPORT 5.02 0001078782-16-003307 000-54296 161843872 34 11913
2016-08-16 NT 10-Q FORM12B25 NOTICE OF LATE FILING 0001078782-16-003271 000-54296 161834440 34 18671
2016-05-26 10-Q/A FORM 10-Q A/1 0001387308-16-000200 000-54296 161678003 34 1430413 1
2016-05-23 10-Q FORM 10-Q 0001387308-16-000198 000-54296 161669492 34 499332
2016-05-13 NT 10-Q FORM 12B-25 0001387308-16-000192 000-54296 161649610 34 25620
2016-04-18 10-K/A FORM 10-K (A/1) 0001387308-16-000190 000-54296 161575627 34 1907425 1
2016-04-14 10-K FORM 10-K (12-31-15) 0001387308-16-000187 000-54296 161571608 34 703031
2016-03-30 NT 10-K NT 10-K 0001387308-16-000179 000-54296 161538295 34 25140
2016-02-19 8-K FORM 8-K 7.01 0001387308-16-000169 000-54296 161439913 34 47015
2016-02-08 8-K FORM 8-K 8.01 0001387308-16-000163 000-54296 161394334 34 20728
2016-02-05 4 PRIMARY DOCUMENT 0001078782-16-002279 4905
2015-12-30 4 PRIMARY DOCUMENT 0001078782-15-002095 6352
2015-12-30 4 PRIMARY DOCUMENT 0001078782-15-002094 8301
2015-11-23 10-Q FORM 10-Q (9-30-15) 0001387308-15-000148 000-54296 151249065 34 1891774 1
2015-11-16 NT 10-Q FORM 12B-25 0001387308-15-000140 000-54296 151233344 34 25909
2015-09-01 8-K FORM 8-K 8.01 0001387308-15-000138 000-54296 151085918 34 20634
2015-08-27 10-Q/A FORM 10-Q (A-1) 0001387308-15-000136 000-54296 151076910 34 1201043 1
2015-08-19 10-Q FORM 10-Q 0001387308-15-000128 000-54296 151064327 34 476878
2015-08-14 NT 10-Q NT 10-Q 0001387308-15-000118 000-54296 151054208 34 24512
2015-08-06 8-K FORM 8-K 7.01 0001387308-15-000112 000-54296 151030783 34 31794
2015-06-18 8-K FORM 8-K 8.01 0001387308-15-000059 000-54296 15940632 34 19327
2015-05-29 S-8 AXIM BIOTECHNOLOGIES, INC. 2015 STOCK INCENTIVE PLAN 0001387308-15-000055 333-204574 15900060 33 187109
2015-05-14 8-K FORM 8-K 1.01,2.01,7.01,9.01 0001387308-15-000044 000-54296 15862974 34 115542
2015-05-13 10-Q FORM 10-Q 0001387308-15-000040 000-54296 15857759 34 1673503 1
2015-04-14 10-K FORM 10-K 0001387308-15-000034 000-54296 15769270 34 10722955 1
2015-03-31 NT 10-K FORM 12B-25 0001387308-15-000022 000-54296 15735771 34 26769
2015-03-24 8-K FORM 8-K 8.01 0001387308-15-000018 000-54296 15720310 34 20869
2015-03-03 4 PRIMARY DOCUMENT 0001078782-15-000331 4863
2015-01-28 8-K FORM 8-K 8.01 0001387308-15-000002 000-54296 15554479 34 24560
2014-11-28 8-K FORM 8-K 1.01 0001387308-14-000150 000-54296 141254573 34 20440
2014-11-14 10-Q FORM 10-Q 0001387308-14-000135 000-54296 141220077 34 17748293 1
2014-11-06 8-K FORM 8-K 8.01 0001387308-14-000130 000-54296 141198377 34 23340
2014-10-23 D xslFormDX01/primary_doc.xml 06b 0001140361-14-038813 021-226987 141168567 33 7457
2014-08-26 10-Q/A FORM 10-Q (A/1) 0001387308-14-000117 000-54296 141063588 34 857502 1
2014-08-19 10-Q FORM 10-Q (6-30-14) 0001387308-14-000113 000-54296 141051976 34 15738011
2014-08-13 NT 10-Q FORM 12B-25 (6-30-14) 0001387308-14-000096 000-54296 141037327 34 26613
2014-07-21 8-K FORM 8-K 4.01,9.01 0001387308-14-000094 000-54296 14985073 34 36100
2014-07-07 DEF 14C DEF 14C 0001387308-14-000081 000-54296 14963460 34 92803
2014-07-07 UPLOAD filename1.pdf 0000000000-14-033982 36991
2014-06-30 CORRESP filename1.htm 0001387308-14-000078 12538
2014-06-26 UPLOAD filename1.pdf 0000000000-14-032520 135847
2014-06-18 10-Q/A FORM 10-Q/A AMENDED QUARTERLY REPORT MARCH 31, 2014 0001078782-14-001122 000-54296 14928660 34 673325 1
2014-06-16 PRER14C SCHEDULE 14C 0001387308-14-000064 000-54296 14911342 34 86170
2014-06-13 CORRESP filename1.htm 0001387308-14-000066 28587
2014-06-09 8-K/A FORM 8-K 5.01 0001387308-14-000062 000-54296 14898915 34 20919
2014-06-09 CORRESP filename1.htm 0001387308-14-000061 12101
2014-06-05 UPLOAD filename1.pdf 0000000000-14-028648 146297
2014-06-03 UPLOAD filename1.pdf 0000000000-14-027986 36491
2014-05-29 CORRESP filename1.htm 0001387308-14-000058 14601
2014-05-29 8-K/A FORM 8-K 4.01 0001387308-14-000056 000-54296 14875682 34 30730
2014-05-28 UPLOAD filename1.pdf 0000000000-14-027147 157283
2014-05-23 PRE 14C PRE 14C 0001387308-14-000052 000-54296 14867358 34 90497
2014-05-23 CORRESP filename1.htm 0001387308-14-000054 16896
2014-05-23 8-K FORM 8-K 5.01 0001387308-14-000047 000-54296 14864934 34 19947
2014-05-20 10-Q FORM 10-Q (3-31-14) 0001387308-14-000045 000-54296 14857575 34 236801
2014-05-20 8-K FORM 8-K 4.01 0001387308-14-000043 000-54296 14857564 34 29727
2014-05-20 UPLOAD filename1.pdf 0000000000-14-025600 170531
2014-05-14 NT 10-Q FORM 12B-25 (3-31-14) 0001387308-14-000037 000-54296 14840948 34 26134
2014-05-02 PRE 14C PRELIMINARY 14C INFORMATION STATEMENT 0001078782-14-000784 000-54296 14810541 34 8640703
2014-04-30 4 PRIMARY DOCUMENT 0001514955-14-000004 5814
2014-04-28 SC 13D SCHEDULE 13D 0001078782-14-000743 005-88107 14786599 34 8613171
2014-04-25 3 PRIMARY DOCUMENT 0001078782-14-000748 4030
2014-04-25 3 PRIMARY DOCUMENT 0001078782-14-000747 4502
2014-04-25 3 PRIMARY DOCUMENT 0001078782-14-000746 4507
2014-04-25 3 PRIMARY DOCUMENT 0001078782-14-000745 4305
2014-04-25 3 PRIMARY DOCUMENT 0001078782-14-000744 4040
2014-04-25 SC 13D SCHEDULE 13D 0001078782-14-000741 005-88107 14786546 34 8626142
2014-04-01 8-K FORM 8-K 5.02 0001387308-14-000031 000-54296 14731628 34 37515
2014-03-04 10-K axim10k2013final.htm 0001514955-14-000003 000-54296 14663563 34 2522072 1
2014-01-28 5 PRIMARY DOCUMENT 0001514955-14-000001 4403
2013-11-18 10-Q aximsept302013final.htm 0001514955-13-000030 000-54296 131227631 34 953217 1
2013-11-08 NT 10-Q aximnt10qsept302013.htm 0001514955-13-000026 000-54296 131203538 34 22096
2013-08-14 10-Q aximjune302013final.htm 0001514955-13-000021 000-54296 131037504 34 1343639 1
2013-08-12 NT 10-Q aximnt10qjune302013.htm 0001514955-13-000019 000-54296 131029267 34 20813
2013-05-15 10-Q aximmarch312013final.htm 0001514955-13-000017 000-54296 13843142 34 947056 1
2013-05-13 NT 10-Q aximnt10qmarch312013.htm 0001514955-13-000015 000-54296 13837463 34 20844
2013-04-15 10-K axim10k2012edgarxbrl04032013.htm 0001514955-13-000012 000-54296 13761212 34 2341845 1
2013-03-28 NT 10-K aximnt10k2012.htm 0001514955-13-000003 000-54296 13722183 34 20709
2013-01-18 5 PRIMARY DOCUMENT 0001514955-13-000001 4402
2012-11-29 8-K axim8k09282012.htm 1.01,9.01 0001514955-12-000031 000-54296 121229870 34 25752
2012-11-19 10-Q aximsept30201210qfinal.htm 0001514955-12-000029 000-54296 121215448 34 742378 1
2012-11-09 NT 10-Q aximnt10qsept2012.htm 0001514955-12-000025 000-54296 121193998 34 22308
2012-08-14 10-Q aximjune30201210qfinal.htm 0001514955-12-000023 000-54296 121033474 34 766774 1
2012-08-14 NT 10-Q aximnt10qjune2012.htm 0001514955-12-000021 000-54296 121028895 34 20784
2012-07-25 8-K axim8kjuly252012.htm 1.01 0001514955-12-000017 000-54296 12978799 34 16536
2012-05-17 10-Q axim0331201210qfinalmay16.htm 0001514955-12-000015 000-54296 12851772 34 696183 1
2012-05-14 NT 10-Q aximnt10qmarch2012.htm 0001514955-12-000011 000-54296 12838050 34 22276
2012-05-01 10-K/A axim10k2011xbrlfinal04162012.htm 0001514955-12-000009 000-54296 12800084 34 1338891 1
2012-04-16 10-K axim10k2011xbrlfinal04162012.htm 0001514955-12-000006 000-54296 12760663 34 1319170 1
2012-03-26 NT 10-K aximnt10k2011.htm 0001514955-12-000002 000-54296 12714340 34 22109
2012-01-05 5 PRIMARY DOCUMENT 0001514946-12-000001 4387
2011-11-21 10-Q/A axim10qaform.htm 0001514946-11-000005 000-54296 111218361 34 485764 1
2011-11-17 10-Q aximreportfor93011final.htm 0001514955-11-000032 000-54296 111213980 34 188798
2011-11-09 NT 10-Q aximnt10qsept2011.htm 0001514955-11-000030 000-54296 111191397 34 22660
2011-11-01 8-K axim-changeinshellcostatus8k.htm 2.01,5.06 0001514955-11-000028 000-54296 111171516 34 253601
2011-10-07 8-K axim8koct62011.htm 3.02 0001514946-11-000002 000-54296 111132823 34 15443
2011-09-01 UPLOAD filename1.pdf 0000000000-11-052377 45461
2011-07-13 3 PRIMARY DOCUMENT 0001514955-11-000026 4013
2011-07-07 10-12G/A aximform10a207062011.htm 0001514955-11-000025 000-54296 11954533 34 427676
2011-06-14 10-12G/A aximform10a106132011.htm 0001514955-11-000022 000-54296 11910978 34 401199
2011-06-07 UPLOAD filename1.pdf 0000000000-11-035001 90396
2011-05-13 10-12G aximform10may122011.htm 0001514955-11-000019 000-54296 11841069 34 142838
2011-05-06 15-12G aximform15may62011.htm 0001514955-11-000015 000-54296 11819493 34 7610
2011-04-19 10-12G/A aximform10a1.htm 0001514955-11-000009 000-54296 11767854 34 143195
2011-03-10 10-12G aximform10final.htm 0001514955-11-000003 000-54296 11678325 34 147335

Latest XBRL company facts

One latest value per concept from companyfacts (510 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 301.96M 2024-08-16 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2021-05-24 2021 Q1 10-Q/A 2021-06-02 0001078782-21-000516
dei EntityPublicFloat Entity Public Float USD 5.34M 2023-06-30 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap AccountsAndNotesReceivableNet Accounts and Financing Receivable, after Allowance for Credit Loss USD 0 2022-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.67M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 1.18M 2023-03-31 2023 Q1 10-Q 2023-05-22 0001096906-23-001168
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 274,520 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap AccountsPayableCurrent Accounts Payable, Current USD -54,389 2014-03-21 2014 Q3 10-Q 2014-11-14 0001387308-14-000135
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 100 2011-09-30 2011 Q3 10-Q/A 2011-11-21 0001514946-11-000005
us-gaap AccountsPayableRelatedPartiesCurrentAndNoncurrent Accounts Payable, Related Parties USD 30,610 2012-06-30 2012 Q2 10-Q 2012-08-14 0001514955-12-000023
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 11,000 2013-12-31 2014 Q1 10-Q 2014-06-18 0001078782-14-001122
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 0 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 11,873 2021-06-30 2021 Q2 10-Q 2021-08-23 0001096906-21-002137
us-gaap AccretionExpense Accretion Expense USD 32,944 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-23 0001096906-22-001257
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 2,840 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 0 2022-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 141,638 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AcquisitionCosts Acquisition Costs, Period Cost USD 192,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AdditionalCollateralAggregateFairValue Additional Collateral, Aggregate Fair Value USD 814,555 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AdditionalLiabilityLongDurationInsuranceAfterReinsurance Additional Liability, Long-Duration Insurance, after Reinsurance USD 25,369 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap AdditionalLiabilityLongDurationInsuranceCurrentWeightedAverageDiscountRate Additional Liability, Long-Duration Insurance, Current Weighted-Average Discount Rate pure 0.06 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 65.18M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AdjustmentForAmortization Amortization USD 42,858 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 9,613 2024-04-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 414,839 2020-07-01 2020-09-30 2020 Q3 10-Q/A 2020-11-27 0001078782-20-000923
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 91,526 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-23 0001096906-21-002137
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 21,404 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2014-06-30 2014 Q2 10-Q 2014-08-26 0001387308-14-000117
us-gaap AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) USD -8,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001387308-14-000135
us-gaap AmortizationOfCapitalizedValueOfBusinessAcquiredAsset Amortization of Capitalized Value of Business Acquired Asset (Deprecated 2015-01-31) USD 832 2010-11-18 2011-12-31 2011 FY 10-K/A 2012-05-01 0001514955-12-000009
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 120,697 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 210,094 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 459,522 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 120,697 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 197,224 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AmortizationOfLeasedAsset Amortization of Leased Asset USD 14,958 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AmortizationOfRegulatoryAsset Amortization of Regulatory Asset USD 187,562 2022-01-01 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 382.73M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap Assets Assets USD 3.73M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AssetsCurrent Assets, Current USD 20,243 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap AssetsFairValueAdjustment Assets, Fair Value Adjustment USD -90,887 2020-04-01 2020-06-30 2021 Q2 10-Q 2021-08-23 0001096906-21-002137
us-gaap AssetsNoncurrent Assets, Noncurrent USD 10.48M 2021-03-31 2021 Q1 10-Q/A 2021-06-02 0001078782-21-000516
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 562,392 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 510,017 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 65,000 2015-05-01 2015-05-11 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 186,492 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 92,645 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 93,847 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap Cash Cash USD 23,220 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 79,814 2020-01-01 2020-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 53,542 2023-03-31 2023 Q1 10-Q 2023-05-22 0001096906-23-001168
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -7,967 2021-01-01 2021-03-31 2021 Q1 10-Q/A 2021-06-02 0001078782-21-000516
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 0 2010-12-31 2011 Q3 10-Q/A 2011-11-21 0001514946-11-000005
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 6,044 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -150,413 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -4,218 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 127 2010-11-18 2013-12-31 2013 FY 10-K 2014-03-04 0001514955-14-000003
us-gaap CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations Cash Provided by (Used in) Financing Activities, Discontinued Operations USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.315 2022-01-31 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap ClosedBlockOperationsIncomeLossFromDiscontinuedOperationsNetOfTax Closed Block Operations, Income (Loss) from Discontinued Operations, Net of Tax USD 0 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap ClosedBlockOperationsNetResults Closed Block Operations, Net Results USD 20,000 2018-12-25 2019-01-02 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap CommonStockDividendsShares Common Stock Dividends, Shares shares 5.83M 2015-05-01 2015-05-11 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap CommonStockHeldBySubsidiary Common Stock Held by Subsidiary USD 135,000 2022-06-30 2022 Q2 10-Q 2022-08-16 0001096906-22-001922
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1.00B 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 294.46M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 294.46M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 24,475 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap CommonStockValue Common Stock, Value, Issued USD 29,446 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap CompensatingBalanceAmount Compensating Balance, Amount USD 141,125 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 0 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 1 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 7.80M 2020-09-30 2020 Q3 10-Q/A 2020-11-27 0001078782-20-000923
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 380,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-20 0001096906-24-001202
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 30,858 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 367,931 2022-01-01 2022-01-27 2023 Q1 10-Q 2023-05-22 0001096906-23-001168
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 356.36M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 761,604 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 5.04M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 4.21M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 4.25M 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap ConvertibleSubordinatedDebtCurrent Convertible Subordinated Debt, Current USD 50,000 2015-03-31 2015 Q1 10-Q 2015-05-13 0001387308-15-000040
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 1,744 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap CostOfGoodsAndServicesSoldDepreciation Cost, Depreciation USD 23,451 2022-01-01 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 38,930 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap CostOfRevenue Cost of Revenue USD 0 2021-01-01 2021-03-31 2021 Q1 10-Q/A 2021-06-02 0001078782-21-000516
us-gaap CostsAndExpenses Costs and Expenses USD 1,411 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 380,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 1.00M 2023-01-01 2023-12-31 2024 Q1 10-Q/A 2024-05-22 0001096906-24-001225
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 75,074 2020-01-01 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 100,000 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 1.54M 2021-11-07 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 340,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.031 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap DebtInstrumentConvertibleEffectiveInterestRate Debt Instrument, Convertible, Effective Interest Rate (Deprecated 2013-01-31) pure 0.1 2012-07-01 2012-07-20 2012 Q2 10-Q 2012-08-14 0001514955-12-000023
us-gaap DebtInstrumentConvertibleLiquidationPreferencePerShare DebtInstrumentConvertibleLiquidationPreferencePerShare USD/shares 0.02 2024-03-15 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 380,858 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.03 2022-12-01 2022-12-09 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap DebtInstrumentInterestRateIncreaseDecrease Debt Instrument, Interest Rate, Increase (Decrease) pure 0.038 2023-05-01 2023-05-23 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.043 2024-03-15 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 1.79M 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 275,607 2018-06-30 2018 Q2 10-Q 2018-08-17 0001078782-18-000892
us-gaap DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1 Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net USD -227,459 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 0 2022-06-30 2022 Q2 10-Q 2022-08-16 0001096906-22-001922
us-gaap DeferredRevenue Deferred Revenue USD 96,189 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 9,929 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 232,669 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 118,965 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 66,376 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 608,354 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 0 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 7.80M 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2019-12-31 2019 FY 10-K/A 2020-05-20 0001078782-20-000359
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 9.72M 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 967,019 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 10.04M 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap DeferredTaxLiabilityIntraEntityTransferAssetOtherThanInventory Deferred Tax Liability, Intra-entity Transfer, Asset Other than Inventory USD 2.34M 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityBadDebtReserveForTaxPurposesOfQualifiedLender Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Bad Debt Reserve for Tax Purposes of Qualified Lender USD 2.34M 2021-03-31 2021 Q1 10-Q/A 2021-06-02 0001078782-21-000516
us-gaap DepositLiabilityCurrent Deposit Liability, Current USD 275,000 2019-06-30 2019 Q2 10-Q 2019-08-14 0001078782-19-000672
us-gaap DepositsAssets Deposits Assets USD 0 2019-06-30 2019 Q2 10-Q 2019-08-14 0001078782-19-000672
us-gaap Depreciation Depreciation USD 18,670 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DepreciationAmortizationAndAccretionNet Depreciation, Amortization and Accretion, Net USD 839 2020-01-01 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 216,136 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DepreciationNonproduction Depreciation, Nonproduction USD 20,119 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap DerivativeAssetsLiabilitiesAtFairValueNet Derivative Assets (Liabilities), at Fair Value, Net USD 4.12M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 1.09M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DerivativeGainOnDerivative Derivative, Gain on Derivative USD 3.24M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap DerivativeLiabilities Derivative Liability USD 4.12M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 4.12M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 693,515 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD -161,403 2014-06-30 2014 Q2 10-Q 2014-08-26 0001387308-14-000117
us-gaap DirectOperatingMaintenanceSuppliesCosts Direct Operating Maintenance Supplies Costs USD 34,911 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD 0 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share USD/shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share USD/shares 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-16 0001096906-22-001922
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities USD 210,640 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap DisposalGroupIncludingDiscontinuedOperationIntangibleAssets Disposal Group, Including Discontinued Operation, Intangible Assets USD 47,375 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingExpense Disposal Group, Including Discontinued Operation, Operating Expense USD 0 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherAssets Disposal Group, Including Discontinued Operation, Other Assets USD 0 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets Disposal Group, Including Discontinued Operation, Other Assets, Current USD 5,000 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherIncome Disposal Group, Including Discontinued Operation, Other Income USD 0 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap DueFromRelatedParties Due from Related Parties USD 103,242 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap DueToAffiliateCurrent Due to Affiliate, Current USD 609,835 2020-06-30 2020 Q2 10-Q/A 2020-08-18 0001078782-20-000653
us-gaap DueToOfficersOrStockholdersCurrent Due to Officers or Stockholders, Current USD 0 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap DueToOtherRelatedPartiesClassifiedCurrent Due to Other Related Parties, Current USD 0 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 1.53M 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 565,083 2015-09-30 2015 Q3 10-Q 2015-11-23 0001387308-15-000148
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 518,948 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.01 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.03 2020-01-01 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.01 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.12 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0.006 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.119 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability Embedded Derivative, Fair Value of Embedded Derivative Liability USD 543,369 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap EmployeeBenefitsAndShareBasedCompensationNoncash Employee Benefit and Share-based Payment Arrangement, Noncash USD 1.00M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001078782-18-001314
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 0.001 2011-09-01 2011-09-30 2013 FY 10-K 2014-03-04 0001514955-14-000003
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 1 2020-03-06 2022 Q2 10-Q 2022-08-16 0001096906-22-001922
us-gaap ExcessCapital Banking Regulation, Total Risk-Based Capital, Excess, Actual USD 107,841 2014-06-30 2014 Q2 10-Q 2014-08-26 0001387308-14-000117
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 261,537 2023-01-05 2023-01-23 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ExtinguishmentOfDebtGainLossIncomeTax Extinguishment of Debt, Gain (Loss), Income Tax USD 0 2019-01-01 2019-12-31 2019 FY 10-K/A 2020-05-20 0001078782-20-000359
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD -162,811 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 675,000 2022-07-01 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD 765,556 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 231,873 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 94,829 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 162,410 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 1.12M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 1.64M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 197,224 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 391,230 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 391,230 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 391,230 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 391,230 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 4.52M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 3.69M 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 250,000 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap GainLossOnCondemnation Gain (Loss) on Condemnation USD -923,604 2020-01-01 2020-09-30 2020 Q3 10-Q/A 2020-11-27 0001078782-20-000923
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 955,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 43,688 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost USD 626,414 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 5.67M 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap Goodwill Goodwill USD 0 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 2.46M 2020-09-01 2020-09-30 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 2.46M 2020-09-01 2020-09-30 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap GrossProfit Gross Profit USD 68,714 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 295,834 2022-01-01 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD -641,096 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-23 0001096906-21-002137
us-gaap IncomeLossAttributableToParent Income (Loss) Attributable to Parent, before Tax USD -6.16M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -2.56M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -506,946 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001387308-15-000040
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 4.27M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -4.69M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-23 0001096906-21-002137
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.27 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-18 0001387308-16-000190
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares 0.04 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares 0.04 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-18 0001387308-16-000190
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-04 0001514955-14-000003
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap IncomeTaxHolidayAggregateDollarAmount Income Tax Holiday, Aggregate Dollar Amount USD 261,537 2023-01-05 2023-01-23 2023 Q1 10-Q 2023-05-22 0001096906-23-001168
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 5,500 2010-11-18 2011-12-31 2011 FY 10-K/A 2012-05-01 0001514955-12-000009
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 300,247 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -770 2021-01-01 2021-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-22 0001096906-23-001168
us-gaap IncreaseDecreaseInCustomerAdvancesAndDeposits Increase (Decrease) in Customer Advances and Deposits USD 47,720 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 13,383 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-04 0001514955-14-000003
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -70,458 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD -255 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap IncreaseDecreaseInDerivativeAssetsAndLiabilities Increase (Decrease) in Derivative Assets and Liabilities USD 270,087 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD -418,769 2022-01-01 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD -29,011 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001387308-15-000040
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD -9,795 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap IncreaseDecreaseInInsuranceAssets Increase (Decrease) in Insurance Assets USD -22,978 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap IncreaseDecreaseInIntangibleAssetsCurrent Increase (Decrease) in Intangible Assets, Current USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-18 0001387308-16-000190
us-gaap IncreaseDecreaseInInterestAndDividendsReceivable Increase (Decrease) in Interest and Dividends Receivable USD 1,701 2022-01-01 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-18 0001078782-18-000580
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -20,089 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap IncreaseDecreaseInOtherAccountsPayable Increase (Decrease) in Other Accounts Payable USD 286 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-09-14 0001078782-17-001266
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -2,750 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001387308-14-000135
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 8,618 2020-01-01 2020-09-30 2020 Q3 10-Q/A 2020-11-27 0001078782-20-000923
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 9,825 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap IncreaseDecreaseInOtherDeferredLiability Increase (Decrease) in Other Deferred Liability USD 7,785 2020-01-01 2020-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -8,000 2010-11-19 2014-06-30 2014 Q2 10-Q 2014-08-26 0001387308-14-000117
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -3,342 2020-01-01 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 514 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-23 0001096906-21-002137
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -103,230 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap IncreaseDecreaseInPrepaidInsurance Increase (Decrease) in Prepaid Insurance USD 94,779 2020-01-01 2020-09-30 2020 Q3 10-Q/A 2020-11-27 0001078782-20-000923
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 20,089 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap IncreaseDecreaseInRoyaltiesPayable Increase (Decrease) in Royalties Payable USD 449 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-09-14 0001078782-17-001266
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD -7,440 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 20.00M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap IndefiniteLivedLicenseAgreements Indefinite-Lived License Agreements USD 4.27M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap InformationTechnologyAndDataProcessing Information Technology and Data Processing USD 8,746 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-04 0001514955-14-000003
us-gaap IntangibleAssetsCurrent Intangible Assets, Current USD 63,167 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 0 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 9.74M 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 3.40M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap InterestExpense Interest Expense USD 341,840 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap InterestExpenseDebt Interest Expense, Debt USD 70,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 809,344 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001096906-23-001655
us-gaap InterestExpenseOther Interest Expense, Other USD 1.03M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-09-14 0001078782-17-001262
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 175,915 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap InterestIncomeOther Interest Income, Other USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap InterestIncomeSecuritiesTaxExempt Interest Income, Securities, Operating, Tax Exempt USD 769 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap InterestOnConvertibleDebtNetOfTax Interest on Convertible Debt, Net of Tax USD 367,931 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 203,369 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap InterestPayableCurrent Interest Payable, Current USD 254,865 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap InventoryNet Inventory, Net USD 20,089 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 0 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 0 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap InventoryWriteDown Inventory Write-down USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001078782-18-000306
us-gaap InvestmentIncomeAmortizationOfDiscount Investment Income, Amortization of Discount USD 35,591 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-23 0001096906-22-001257
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1,026 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 238,033 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 4.00M 2020-05-01 2024 Q1 10-Q/A 2024-05-22 0001096906-24-001225
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 27,490 2020-09-30 2020 Q3 10-Q/A 2020-11-27 0001078782-20-000923
us-gaap InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions Investments in and Advances to Affiliates, at Fair Value, Gross Additions USD 0 2020-01-01 2020-06-30 2020 Q2 10-Q/A 2020-08-18 0001078782-20-000653
us-gaap InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions Investments in and Advances to Affiliates, at Fair Value, Gross Reductions USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q/A 2020-11-27 0001078782-20-000923
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 114,522 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap LeaseCost Lease, Cost USD 89,708 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap LeaseDepositLiability Lease Deposit Liability USD 58,540 2021-06-30 2021 Q2 10-Q 2021-08-23 0001096906-21-002137
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 196,380 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 50,010 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 43,686 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 102,684 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 186,492 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap Liabilities Liabilities USD 13.26M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 3.73M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 1.84M 2020-01-01 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap LiabilitiesCurrent Liabilities, Current USD 6.57M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 6.69M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap LineOfCreditFacilityFairValueOfAmountOutstanding Line of Credit Facility, Fair Value of Amount Outstanding USD 3.24M 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 955,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LitigationSettlementInterest Litigation Settlement Interest USD 4,196 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap LoansAssumed1 Loans Assumed USD 128,375 2019-12-01 2019-12-31 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap LoansReceivableNet Loans Receivable, Net (Deprecated 2019-01-31) USD 5,000 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap LongTermDebt Long-term Debt USD 5.97M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 93,847 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 92,645 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LongtermDebtWeightedAverageInterestRate Long-term Debt, Weighted Average Interest Rate, at Point in Time pure 0.035 2020-05-01 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 1.37M 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap LossContingencyReceivableProceeds Loss Contingency, Receivable, Proceeds USD 40,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap MarketableSecurities Marketable Securities USD 0 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 0 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 0 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD -104,705 2020-01-01 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD -252,506 2024-01-01 2024-03-31 2024 Q1 10-Q/A 2024-05-22 0001096906-24-001225
us-gaap NetCashProvidedByUsedInDiscontinuedOperations Net Cash Provided by (Used in) Discontinued Operations USD 4,633 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 366,474 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 148,219 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-22 0001096906-23-001168
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -2,839 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -8,710 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -514,048 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -2.04M 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -2.56M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -6.24M 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest USD -3.83M 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-23 0001096906-21-002137
us-gaap NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 Noncash or Part Noncash Divestiture, Amount of Consideration Received USD 71,782 2020-01-01 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap NoninterestExpense Noninterest Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 953,759 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-23 0001096906-22-001257
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 5,000 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap NotesAssumed1 Notes Assumed USD 30,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001387308-14-000135
us-gaap NotesIssued1 Notes Issued USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001078782-18-001314
us-gaap NotesPayable Notes Payable USD 0 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 974,236 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap NotesReceivableRelatedParties Notes Receivable, Related Parties USD 0 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 3.23M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-23 0001387308-15-000148
us-gaap OperatingExpenses Operating Expenses USD 1.04M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -971,006 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap OperatingLeaseCost Operating Lease, Cost USD 70,633 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 58,171 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 34,374 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 182,686 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 20,000 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 20,000 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 20,000 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 20,000 2022-06-30 2022 Q2 10-Q 2022-08-16 0001096906-22-001922
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 14,562 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 900 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-04 0001514955-14-000003
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 9.02M 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap OptionContractIndexedToEquitySettlementShareFairValuePerShare OptionContractIndexedToEquitySettlementShareFairValuePerShare USD/shares 0.13 2020-05-01 2024 Q1 10-Q/A 2024-05-22 0001096906-24-001225
us-gaap OptionIndexedToIssuersEquityShares Option Indexed to Issuer's Equity, Shares shares 1.00M 2023-08-27 2023-09-01 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap OptionIndexedToIssuersEquityStrikePrice1 Option Indexed to Issuer's Equity, Strike Price USD/shares 0.023 2023-08-27 2023-09-01 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap OtherAmortizationOfDeferredCharges Amortization of Other Deferred Charges USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001078782-18-000306
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 5.85M 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap OtherAssets Other Assets USD 3.59M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap OtherAssetsCurrent Other Assets, Current USD 13,839 2022-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 6.50M 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 15,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-04 0001514955-14-000003
us-gaap OtherExpenses Other Expenses USD 47,834 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 3,636 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-04 0001514955-14-000003
us-gaap OtherGeneralExpense Other General Expense USD 1,970 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-04 0001514955-14-000003
us-gaap OtherIncome Other Income USD 5,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap OtherIntangibleAssetsNet Other Intangible Assets, Net USD 3.40M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 0 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap OtherNoncashIncome Other Noncash Income USD 57,400 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001078782-19-000861
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 203,429 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.59M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 0 2010-11-19 2014-06-30 2014 Q2 10-Q 2014-08-26 0001387308-14-000117
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 0 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap OtherReceivables Other Receivables USD 89,568 2019-09-30 2019 Q3 10-Q 2019-11-14 0001078782-19-000861
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q/A 2020-07-02 0001078782-20-000525
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationReceived1 Other Significant Noncash Transaction, Value of Consideration Received USD 0 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap PaymentsForAdvanceToAffiliate Payments for Advance to Affiliate USD -24,510 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-14 0001514955-12-000023
us-gaap PaymentsForFees Payments for Other Fees USD 20,000 2021-01-01 2021-12-31 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 102,387 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap PaymentsForRent Payments for Rent USD 4,854 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 1.32M 2022-01-01 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap PaymentsToAcquireBusinessesAndInterestInAffiliates Payments to Acquire Businesses and Interest in Affiliates USD -50,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-19 0001514955-12-000029
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 2.61M 2020-05-01 2020-05-06 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap PaymentsToAcquireInterestInJointVenture Payments to Acquire Interest in Joint Venture USD 0 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 2,839 2024-01-01 2024-03-31 2024 Q1 10-Q/A 2024-05-22 0001096906-24-001225
us-gaap PaymentsToFundLongtermLoansToRelatedParties Payments to Fund Long-term Loans to Related Parties USD 65,000 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-18 0001078782-18-000580
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 300.00M 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 300.00M 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap PreferredStockSharesSubscribedButUnissuedValue Preferred Stock, Value, Subscriptions USD 0 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 50 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 0 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 69,734 2022-03-31 2022 Q1 10-Q 2022-05-23 0001096906-22-001257
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 5,000 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap PrepaidInsurance Prepaid Insurance USD 0 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap ProceedsFromAdvancesForConstruction Proceeds from Advances for Construction USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-18 0001387308-16-000190
us-gaap ProceedsFromCollectionOfLongtermLoansToRelatedParties Proceeds from Collection of Long-term Loans to Related Parties USD 50,002 2010-11-19 2014-06-30 2014 Q2 10-Q 2014-08-26 0001387308-14-000117
us-gaap ProceedsFromCollectionOfNotesReceivable Proceeds from Collection of Notes Receivable USD 40,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-22 0001096906-23-001168
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 200,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ProceedsFromDivestitureOfInterestInJointVenture Proceeds from Divestiture of Interest in Joint Venture USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap ProceedsFromIssuanceOfMediumTermNotes Proceeds from Issuance of Medium-term Notes USD 850,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-30 0001078782-16-003875
us-gaap ProceedsFromIssuanceOfRedeemablePreferredStock Proceeds from Issuance of Redeemable Preferred Stock USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001078782-18-000306
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 129,274 2021-05-15 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap ProceedsFromLoans Proceeds from Loans USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-08 0001078782-19-000304
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 0 2019-01-01 2019-12-31 2019 FY 10-K/A 2020-05-20 0001078782-20-000359
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-18 0001387308-16-000190
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 47,741 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-16 0001096906-22-001922
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 50,000 2019-01-01 2019-12-31 2019 FY 10-K/A 2020-05-20 0001078782-20-000359
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001078782-19-000861
us-gaap ProceedsFromRepaymentOfLoansToPurchaseCommonStock Proceeds from Repayment of Loans to Purchase Common Stock USD 25,000 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap ProceedsFromSaleOfLoansReceivable Proceeds from Sale of Loans Receivable USD 500,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 70,828 2020-01-01 2020-06-30 2020 Q2 10-Q/A 2020-08-18 0001078782-20-000653
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 250,000 2022-02-01 2022-02-10 2024 Q1 10-Q 2024-05-20 0001096906-24-001202
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 575,000 2023-05-01 2023-05-23 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ProfessionalFees Professional Fees USD 23,826 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-04 0001514955-14-000003
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -2.56M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 259,631 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease Property, Plant and Equipment, Gross, Period Increase (Decrease) USD -2,839 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 117,993 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001387308-15-000040
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 0 2010-11-19 2014-06-30 2014 Q2 10-Q 2014-08-26 0001387308-14-000117
us-gaap RecognitionOfDeferredRevenue Recognition of Deferred Revenue USD 45,500 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap RelatedPartyTransactionDueFromToRelatedParty Related Party Transaction, Due from (to) Related Party USD 13,609 2015-03-31 2015 Q1 10-Q 2015-05-13 0001387308-15-000040
us-gaap RelatedPartyTransactionRate Related Party Transaction, Rate pure 0.06 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-14 0001514955-12-000023
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD -1.97M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001078782-18-001314
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 1.24M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap RepaymentsOfDebt Repayments of Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 90,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 25,369 2021-01-01 2021-03-31 2021 Q1 10-Q/A 2021-06-02 0001078782-21-000516
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2020-01-01 2020-06-30 2020 Q2 10-Q/A 2020-08-18 0001078782-20-000653
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 19,349 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 0 2021-01-01 2021-03-31 2021 Q1 10-Q/A 2021-06-02 0001078782-21-000516
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 5.85M 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD 332,500 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -74.75M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-16 0001096906-22-001922
us-gaap Revenues Revenues USD 70,458 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap RevenuesNetOfInterestExpense Revenues, Net of Interest Expense USD 47,524 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-23 0001096906-21-002137
us-gaap RoyaltyGuaranteesCommitmentsAmount Royalty Guarantees, Commitments, Amount USD 2,750 2013-12-31 2014 Q1 10-Q 2014-06-18 0001078782-14-001122
us-gaap SalariesWagesAndOfficersCompensation Salary and Wage, Excluding Cost of Good and Service Sold USD 105,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 21,667 2013-01-01 2013-09-30 2014 Q3 10-Q 2014-11-14 0001387308-14-000135
us-gaap SecurityDeposit Security Deposit USD 9,014 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 804,235 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap SeveranceCosts1 Severance Costs USD 102,387 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 19,226 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 18.57M 2020-05-01 2020-05-06 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 2.24 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.035 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 24.12M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 22.54M 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.13 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 2.00M 2021-01-01 2021-12-31 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 2.00M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 0.75 2021-01-01 2021-12-31 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 13.50M 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 8.30M 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 24.12M 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.13 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 103,822 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-22 0001096906-23-001168
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.37 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-04-26 0001078782-21-000395
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.052 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate pure 2.27 2022-12-01 2022-12-09 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap SharePrice Share Price USD/shares 0.15 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap SharesIssued Shares, Issued shares 47.73M 2024-03-31 2024 Q1 10-Q/A 2024-05-22 0001096906-24-001225
us-gaap SharesOutstanding Shares, Outstanding shares -2.37M 2016-12-31 2017 Q1 10-Q 2017-09-14 0001078782-17-001264
us-gaap ShortTermBorrowings Short-term Debt USD 180 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap ShorttermDebtFairValue Short-term Debt, Fair Value USD 500,000 2022-02-10 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 99,742 2021-01-01 2021-03-31 2021 Q1 10-Q/A 2021-06-02 0001078782-21-000516
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -9.53M 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 1.04M 2021-06-30 2021 Q2 10-Q 2021-08-23 0001096906-21-002137
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 1,000 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap StockholdersEquityOther Stockholders' Equity, Other USD 24,500 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001078782-18-001314
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 5.83M 2015-05-01 2015-05-11 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 13.00M 2011-09-01 2011-09-30 2013 FY 10-K 2014-03-04 0001514955-14-000003
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 6.00M 2024-01-01 2024-03-31 2024 Q1 10-Q/A 2024-05-22 0001096906-24-001225
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 519,247 2022-01-01 2022-01-31 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 13.50M 2022-07-01 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap StockIssuedDuringPeriodSharesPurchaseOfAssets Stock Issued During Period, Shares, Purchase of Assets shares 17.28M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 500,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 473,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-23 0001387308-15-000148
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationGross Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture shares 77,125 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-23 0001387308-15-000148
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 500,000 2022-01-01 2022-01-11 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 7.51M 2020-01-01 2020-03-31 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 190,000 2020-01-01 2020-03-31 2021 Q3 10-Q 2021-11-22 0001096906-21-002816
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 688,432 2023-01-01 2023-03-31 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 400,000 2019-01-01 2019-03-31 2020 Q3 10-Q/A 2020-11-27 0001078782-20-000923
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 80,080 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.00M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-22 0001096906-23-001168
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 129,274 2021-05-15 2021-12-31 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 72,800 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001096906-24-000864
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 2.56M 2020-05-01 2020-05-06 2021 FY 10-K/A 2022-04-19 0001096906-22-000902
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 182,215 2022-04-01 2022-06-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 0 2022-01-01 2022-03-31 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap StockOptionExercisePriceDecrease Stock Option, Exercise Price, Decrease USD/shares 0.75 2021-03-01 2021-03-31 2022 FY 10-K 2023-04-17 0001096906-23-000858
us-gaap StockOrUnitsAvailableForDistributions Stock or Units Available for Distributions shares 24.12M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 1,857 2020-04-01 2020-06-30 2020 Q3 10-Q/A 2020-11-27 0001078782-20-000923
us-gaap SupplementalDeferredPurchasePrice Supplemental Deferred Purchase Price USD 349,535 2022-01-12 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap Supplies Prepaid Supplies USD 14,199 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap TaxesAndLicenses Taxes and Licenses USD 150,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001096906-24-001772
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 18.57M 2020-05-06 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap UndistributedEarningsLossAvailableToCommonShareholdersBasic Undistributed Earnings (Loss) Available to Common Shareholders, Basic USD -292,299 2024-01-01 2024-03-31 2024 Q1 10-Q/A 2024-05-22 0001096906-24-001225
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap UnsecuredDebtCurrent Unsecured Debt, Current USD 0 2022-09-30 2022 Q3 10-Q/A 2022-11-15 0001096906-22-002783
us-gaap UtilitiesOperatingExpenseImpairments Utilities Operating Expense, Impairments USD 52,103 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001387308-14-000135
us-gaap UtilitiesOperatingExpenseMaintenanceOperationsAndOtherCostsAndExpenses Utilities Operating Expense, Maintenance, Operations, and Other Costs and Expenses USD 14,894 2010-11-18 2011-12-31 2011 FY 10-K/A 2012-05-01 0001514955-12-000009
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 478.51M 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 147.16M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-23 0001096906-22-001257
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 224.10M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001096906-23-002238

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →